Trial record 5 of 5 for: "Childhood Absence Epilepsy" | "Diuretics, Potassium Sparing"
Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy
|ClinicalTrials.gov Identifier: NCT01118949|
Recruitment Status : Completed
First Posted : May 7, 2010
Results First Posted : September 7, 2012
Last Update Posted : July 17, 2018
UCB BIOSCIENCES, Inc.
Information provided by (Responsible Party):
UCB Pharma ( UCB BIOSCIENCES, Inc. )
|Study Design||Intervention Model: Single Group Assignment; Masking: None (Open Label); Primary Purpose: Treatment|
|Recruitment Details||Safety Set (SS) includes all enrolled subjects who took at least 1 dose of Lacosamide (LCM).|
|Pre-assignment Details||Participant Flow and Baseline Characteristics refer to the Safety Set (SS).|